Featured Research

from universities, journals, and other organizations

New insights into treatment options for patients suffering from severe alcoholic hepatitis

Date:
April 16, 2010
Source:
European Association for the Study of the Liver
Summary:
Results from two French studies will help inform clinical practice in the treatment of patients with severe or acute alcoholic hepatitis.

Results from two French studies presented at the International Liver CongressTM 2010 press conference will help inform clinical practice in the treatment of patients with severe or acute alcoholic hepatitis.

The first study demonstrated the positive potential of performing liver transplantation for patients suffering from severe alcoholic hepatitis (SAH) earlier than the recommended 6-months rule (required minimum of recorded abstinence for an alcoholic patient to be eligible for a liver transplant). Indeed, those patients who do not respond to treatment with steroids have a 6-month survival of around 30% and most deaths actually occur within 2-months. The results show that early liver transplantation could be proposed to non-respondents, pending a very careful evaluation of selected patients.

Acute alcoholic hepatitis (AAH) however, is an absolute contraindication for liver transplantation. It has a low survival rate, with mortality remaining at around 35% at 6 months despite corticoid treatment, the current standard of care for the condition. The second study presented April 16 will help inform a potential new treatment option for those patients who do not respond to standard treatment with corticoid. Data demonstrated that treatment with combined corticoids plus N-acetyl cysteine (C+NAC) showed an increase in survival rates. There have been few, large, well-designed trials advocating the use of N-acetyl cysteine to slow progression of liver disease. This latest study adds to the growing body of evidence in the benefits of treatment with C+NAC in patients with acute liver disease.

Professor Philippe Mathurin from the Hτpital Huriez, CHRU Lille, France who presented the results commented: "Whilst the management of alcoholic hepatitis is steeped in controversy, as clinicians we have a responsibility to treat these patients in the most effective way possible, and as researchers we have a mandate to highlight new options.

These latest results across large patient cohorts are the sort of clinical studies that are vital to help guide best practice in the treatment pathway for difficult-to-treat patients with a challenging medical history. Alongside education and, ideally, prevention strategies we can achieve some successful outcomes.

About the studies

The physiopathology of AAH combines oxidative stress combined with elevated levels of TNF-alpha. The proposal of the first study was that combination of corticoid with N-acetyl cysteine (C+NAC) may rebuild anti-oxidant stocks with anti-inflammatory action. 174 patients across 11 centres in France were randomized into C+NAC or corticoid groups. The study looked at evaluating survival at months one, two, three and six as well as complications from treatment and bilirubin change (marker to evaluate progression of AAH) at day 7 and 14.

Deaths were significantly lower at month 1 for C+NAC group, with the survival rate being increased to some extent at month 2 and 6 for that patient group. The C+NAC group had lower infection and hepatorenal syndrome at both month 2 and 6.

For patients suffering from SAH, non-responders to steroids have a survival rate at 6-months of around 30%. Most deaths however occur within 2 months and early liver transplantation is the logic but controversial solution as it challenges the 6-months abstinence rule for patients. In this trial, six liver transplant centres performed early liver transplantation in patients experiencing their first episode of liver disease who had been drastically selected using the following criteria: absolute consensus of medical and paramedical staff, no co-morbidities and supportive family members. Each transplanted patient was matched to a non-transplanted non-respondent to steroids patient for the case control (control group). Overall twenty patients underwent transplantation.

Results show that 1-year survival was significantly higher in patients who had the transplant compared to the control group. Four out of five transplanted patients died from aspergillosis (a type of fungal infection). In the control group, 90% of the observed deaths occurred within the first two months. The study is still ongoing and two other patients are being evaluated for early transplantation.



Story Source:

The above story is based on materials provided by European Association for the Study of the Liver. Note: Materials may be edited for content and length.


Journal References:

  1. Castel et al. Early transplantation improved survival of non-responders to corticosteroids in severe alcoholic hepatitis: a challenge of the 6 month rule of abstinence. Journal of Hepatology, 2010; 52S13 DOI: 10.1016/S0168-8278(10)60031-1
  2. Nguyen-Khac et al. Treatment of severe Acute Alcoholic Hepatitis (AAH) with Corticoids plus N-Acetyl Cysteine (C NAC) versus Corticoid alone (C): a multicenter, randomized control trial. Journal of Hepatology, 2010; 52S38 DOI: 10.1016/S0168-8278(10)60085-2
  3. Louvet et al. The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology, 2007; 45 (6): 1348 DOI: 10.1002/hep.21607

Cite This Page:

European Association for the Study of the Liver. "New insights into treatment options for patients suffering from severe alcoholic hepatitis." ScienceDaily. ScienceDaily, 16 April 2010. <www.sciencedaily.com/releases/2010/04/100416094130.htm>.
European Association for the Study of the Liver. (2010, April 16). New insights into treatment options for patients suffering from severe alcoholic hepatitis. ScienceDaily. Retrieved September 1, 2014 from www.sciencedaily.com/releases/2010/04/100416094130.htm
European Association for the Study of the Liver. "New insights into treatment options for patients suffering from severe alcoholic hepatitis." ScienceDaily. www.sciencedaily.com/releases/2010/04/100416094130.htm (accessed September 1, 2014).

Share This




More Health & Medicine News

Monday, September 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Get on Your Bike! London Cycling Popularity Soars Despite Danger

Get on Your Bike! London Cycling Popularity Soars Despite Danger

AFP (Sep. 1, 2014) — Wedged between buses, lorries and cars, cycling in London isn't for the faint hearted. Nevertheless the number of people choosing to bike in the British capital has doubled over the past 15 years. Duration: 02:27 Video provided by AFP
Powered by NewsLook.com
We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) — A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) — Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) — California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins